X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ABBOTT INDIA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ABBOTT INDIA PFIZER/
ABBOTT INDIA
 
P/E (TTM) x 36.1 41.1 87.8% View Chart
P/BV x 5.3 10.6 50.2% View Chart
Dividend Yield % 0.6 0.7 98.4%  

Financials

 PFIZER   ABBOTT INDIA
EQUITY SHARE DATA
    PFIZER
Mar-18
ABBOTT INDIA
Mar-18
PFIZER/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2,3656,110 38.7%   
Low Rs1,6253,996 40.7%   
Sales per share (Unadj.) Rs430.31,552.2 27.7%  
Earnings per share (Unadj.) Rs78.7188.8 41.7%  
Cash flow per share (Unadj.) Rs93.2196.4 47.4%  
Dividends per share (Unadj.) Rs20.0055.00 36.4%  
Dividend yield (eoy) %1.01.1 92.1%  
Book value per share (Unadj.) Rs586.5796.6 73.6%  
Shares outstanding (eoy) m45.7521.25 215.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.63.3 142.4%   
Avg P/E ratio x25.326.8 94.7%  
P/CF ratio (eoy) x21.425.7 83.2%  
Price / Book Value ratio x3.46.3 53.6%  
Dividend payout %25.429.1 87.2%   
Avg Mkt Cap Rs m91,271107,376 85.0%   
No. of employees `0002.63.3 79.2%   
Total wages/salary Rs m3,1433,937 79.8%   
Avg. sales/employee Rs Th7,484.89,929.3 75.4%   
Avg. wages/employee Rs Th1,195.01,185.1 100.8%   
Avg. net profit/employee Rs Th1,369.11,207.7 113.4%   
INCOME DATA
Net Sales Rs m19,68532,985 59.7%  
Other income Rs m1,1431,170 97.7%   
Total revenues Rs m20,82834,155 61.0%   
Gross profit Rs m5,0035,245 95.4%  
Depreciation Rs m663162 409.2%   
Interest Rs m438 11.0%   
Profit before tax Rs m5,4796,215 88.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,8782,203 85.3%   
Profit after tax Rs m3,6014,012 89.7%  
Gross profit margin %25.415.9 159.8%  
Effective tax rate %34.335.4 96.7%   
Net profit margin %18.312.2 150.4%  
BALANCE SHEET DATA
Current assets Rs m24,16722,655 106.7%   
Current liabilities Rs m9,5446,681 142.9%   
Net working cap to sales %74.348.4 153.4%  
Current ratio x2.53.4 74.7%  
Inventory Days Days5565 85.0%  
Debtors Days Days2929 98.5%  
Net fixed assets Rs m9,514835 1,138.7%   
Share capital Rs m458213 215.3%   
"Free" reserves Rs m26,37516,715 157.8%   
Net worth Rs m26,83216,928 158.5%   
Long term debt Rs m250-   
Total assets Rs m36,90024,162 152.7%  
Interest coverage x1,305.5163.7 797.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.51.4 39.1%   
Return on assets %9.816.8 58.3%  
Return on equity %13.423.7 56.6%  
Return on capital %20.436.9 55.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m22369 6.1%   
Fx outflow Rs m1,4893,807 39.1%   
Net fx Rs m-1,466-3,438 42.6%   
CASH FLOW
From Operations Rs m3,3181,527 217.3%  
From Investments Rs m-2,383-2,148 110.9%  
From Financial Activity Rs m-1,104-1,024 107.7%  
Net Cashflow Rs m-169-1,646 10.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 7.9 94.9%  
FIIs % 4.9 0.1 4,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.1 138.6%  
Shareholders   85,207 18,270 466.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   VENUS REMEDIES  ORCHID PHARMA LTD  SANOFI INDIA  TTK HEALTHCARE  SHASUN PHARMA  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

JET AIRWAYS Plunges by 5%; BSE 500 Index Down 0.7% (Market Updates)

Sep 19, 2018 | Updated on Sep 19, 2018

JET AIRWAYS share price has plunged by 5% and its current market price is Rs 253. The BSE 500 is down by 0.7%. The top gainers in the BSE 500 Index are UNION BANK (up 4.5%) and MONSANTO INDIA (up 3.7%). The top losers are JET AIRWAYS (down 5.3%) and PFIZER (down 6.8%).

EDELWEISS FINANCIAL Plunges by 5%; BSE 500 Index Down 0.7% (Market Updates)

Sep 19, 2018 | Updated on Sep 19, 2018

EDELWEISS FINANCIAL share price has plunged by 5% and its current market price is Rs 261. The BSE 500 is down by 0.7%. The top gainers in the BSE 500 Index are UNION BANK (up 4.5%) and G.E.SHIPPING (up 4.1%). The top losers are EDELWEISS FINANCIAL (down 5.0%) and PFIZER (down 7.4%).

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 19, 2018 (Close)

TRACK PFIZER

PFIZER - FRESENIUS KABI ONCO. COMPARISON

COMPARE PFIZER WITH

MARKET STATS